ARTICLE | Company News
Amgen, Anthera deal
January 14, 2008 8:00 AM UTC
Amgen granted Anthera exclusive, worldwide rights to AMG 623 to treat systemic lupus erythematosus (SLE) and other undisclosed autoimmune indications. This year, Anthera expects to start Phase II tes...